Peni Ahmadi

Synthetic prodrug design enables biocatalytic activation in mice to elicit tumor growth suppression

Igor Nasibullin, Ivan Smirnov, Peni Ahmadi et al. · Nature Communications · 2022 · 74 citations · Full text

Pharmacy, Medicinal Chemistry, Oncology +14

Dual anti-inflammatory activities of COX-2/5-LOX driven by kratom alkaloid extracts in lipopolysaccharide-induced RAW 264.7 cells

Siti Irma Rahmawati, Dwi Wahyu Indriani, Febby Nurdiya Ningsih et al. · Scientific Reports · 2024 · 32 citations · Full text

Medicine, Immunology, Pharmacology +15

²¹¹At-labeled immunoconjugate <i>via</i> a one-pot three-component double click strategy: practical access to α-emission cancer radiotherapeutics

Katsumasa Fujiki, Yousuke Kanayama, Shinya Yano et al. · Chemical Science · 2018 · 30 citations · Full text

Medicine, Medicinal Chemistry, Oncology +13

Targeted 1,3-dipolar cycloaddition with acrolein for cancer prodrug activation

Ambara R. Pradipta, Peni Ahmadi, Kazuki Terashima et al. · Chemical Science · 2021 · 30 citations · Full text

Pharmacy, Medicinal Chemistry, Oncology +15

A Strategy for Tumor Targeting by Higher‐Order Glycan Pattern Recognition: Synthesis and In Vitro and In Vivo Properties of Glycoalbumins Conjugated with Four Different <i>N</i>‐Glycan Molecules

Ivan Smirnov, Regina Sibgatullina, Sayaka Urano et al. · Small · 2020 · 21 citations

Life Sciences, Medicinal Chemistry, Oncology +15